IP Library Patent Application 17079554
Patent Application
App. No. 17/079,554

NOVEL POLYMORPHIC FORM OF FERRIC MALTOL

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/079,554
Abstract

The present application generally provides ferric maltol of formula I, and more particularly a crystalline form alfa of Ferric maltol, which is characterized by its PXRD pattern as illustrated herein. Corresponding methods for producing the ferric maltol disclosed herein are also provided.

Claims (19)

1 . A crystalline Ferric maltol alfa form characterized by a PXRD pattern having peaks at 9.4, 12.7, 14.4, 15.2, 17.3, 19.8, 21.1, 23, 24.3° 2Θ±0.2° 2Θ.

2 . The crystalline Ferric maltol alfa form of claim 1 , characterized by a PXRD pattern as in FIG. 1 .

3 . A pharmaceutical composition, comprising a highly pure crystalline alfa form of Ferric maltol and one or more pharmaceutically acceptable excipients.

4 . The composition of claim 3 , wherein the crystalline alfa form of Ferric maltol is characterized as in claim 1 .

5 . A process for preparing the crystalline Ferric maltol alfa of claim 1 , comprising:

a) dissolving ferric maltol in at least one solvent;

b) evaporating the solvent at a temperature between about 70° C. and about 100° C.; and

c) isolating alfa Ferric maltol form therefrom.

6 . The process of claim 5 , wherein the ferric maltol is dissolved in a polar aprotic solvent selected from the group consisting of dimethylformamide, dimethylacetamide, dimethylsulfoxide, dichloromethane, and ethyl acetate.

7 . The process of claim 5 , wherein the ferric maltol is dissolved in an ether solvent selected from the group consisting of tetrahydrofuran, dioxane, methyl tertiary butyl ether, and diethyl ether.

8 . The process of claim 5 , wherein the ferric maltol is dissolved in a chloro solvent selected from the group consisting of dichloromethane, chloroform, and dichloroethane.

9 . The process of claim 5 , wherein the ferric maltol is dissolved in an alcoholic solvent selected from the group consisting of methanol, ethanol, isopropanol, and butanol.

10 . A process for preparing a crystalline form of Ferric maltol of formula I comprising:

a) dissolving maltol in water;

b) reacting the maltol solution with ferric chloride hexahydrate in water, in the presence of base sodium hydroxide;

c) adjusting the pH of the solution to about 7 pH;

d) distilling the reaction mixture under vacuum, below 55° C.;

e) dissolving residue in a chloro solvent selected from the group consisting of dichloromethane, chloroform, and dichloroethane;

f) filtering and evaporating the resulting solution under vacuum below 50° C. to obtain ferric maltol.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2024
From: RK PHARMA INC.
To: CITIBANK, N.A.
Reel/Frame 067343/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2022
From: RK PHARMA SOLUTIONS LLC
To: RK PHARMA INC
Reel/Frame 060263/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2021
From: KOVI, RAVISHANKER; KANNAPPAN, JAYARAMAN; THIRUNAVAKARASU, ANANDA BABU; MANDE, HERMANT; PATEL, RAJESH A.
To: RK PHARMA SOLUTIONS LLC
Reel/Frame 054887/0987 →